Hydatidiform moles and the long-term risk of breast cancer (Sweden)

Cancer Causes Control. 2000 Feb;11(2):117-20. doi: 10.1023/a:1008915217389.

Abstract

Objectives: The etiology of breast cancer is only partially understood. Based on the findings that pregnancies reduce breast cancer risk, a possible inverse association between exposure to the placental hormone human chorionic gonadotropin (hCG) and the risk of breast cancer has been suggested. Hydatidiform mole, a gestational trophoblastic disease, is associated with a high expression of hCG. We performed a population-based cohort study in which women with a history of hydatidiform mole were followed up for future cancer outcomes.

Methods: All 3371 women with a notification of hydatidiform mole in the Swedish Cancer Registry between 1958 and 1993 were followed up for future cancer outcomes by record linkages within the registry.

Results: In a total of 57,075 person-years of follow-up, 59 women had a diagnosis of breast cancer during follow-up, yielding an overall standardized incidence ratio of 1.3 (95% CI 1.0-1.7).

Conclusion: This finding is not consistent with the hypothesis of a protective effect of hCG exposure on breast cancer risk, but rather suggests an adverse association.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Distribution
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / epidemiology*
  • Choriocarcinoma / diagnosis
  • Choriocarcinoma / epidemiology*
  • Cohort Studies
  • Comorbidity
  • Confidence Intervals
  • Female
  • Follow-Up Studies
  • Humans
  • Hydatidiform Mole / diagnosis
  • Hydatidiform Mole / epidemiology*
  • Hydatidiform Mole / surgery
  • Incidence
  • Pregnancy
  • Registries
  • Risk Assessment
  • Sweden / epidemiology
  • Uterine Neoplasms / diagnosis
  • Uterine Neoplasms / epidemiology*
  • Uterine Neoplasms / surgery